Posts by Sandra Ansanay-Alex
ONWARD Medical Receives CE Mark for ARC-EX®
ONWARD Medical, a Vaud-Based neurotechnology company, has achieved a major milestone with the CE Mark certification of its ARC-EX® System. This approval allows the company to launch its breakthrough spinal cord stimulation therapy across Europe, both for clinical and home use. The first commercial sales are expected in Q4 2025, starting in Germany before expanding…
Read MoreInkocell Therapeutics secures CHF 150,000 from Venture Kick
EPFL spin-off Inkocell Therapeutics, a Swiss biotech startup developing next-generation cell therapies, has secured CHF 150,000 from Venture Kick. The funding will accelerate the development of Inkocell’s first-in-class NK-tailored CAR (chimeric antigen receptor) technology, designed to create effective, safe, off-the-shelf, and affordable therapies for patients with life-threatening diseases. Over the past decade, engineered T-cell…
Read MoreInnosuisse Supports 7 Promising Swiss Health Valley Startups
Innosuisse has selected 39 new Startup Innovation Projects, providing direct funding to early-stage Swiss companies on the cusp of entering the market. These startups are driving innovation across diverse sectors, from pharma and life sciences to industrial applications and beyond. 7 are located in the Swiss Health Valley. Through its Startup Innovation Projects programme,…
Read MoreTop 100 Startups – the Swiss Health Valley is well represented
The Top100 Swiss Startup Ranking showcases the 100 Swiss startups with the most significant potential. Each year, a jury of 100 startup investors selects the most promising companies that are no older than five years after incorporation. The 2025 ranking reflects the strength, diversity, and innovative power of Switzerland’s startup ecosystem,” says Stefan Steiner,…
Read Morecellvie and CSEM Automate Mitochondrial Isolation to Enable Breakthrough Therapies
cellvie, a pioneer in harnessing the therapeutic potential of mitochondria, is developing a novel treatment for ischemia-reperfusion injuries – a condition affecting over 3 million patients annually in Europe and the U.S, in partnership with CSEM Ischemia-reperfusion injuries occur when blood supply returns to tissue after being restricted, causing extensive damage. They are linked…
Read MoreFIF Funding Supports Four Life Sciences Startups: Reverso Therapeutics, Harantech, Vibrant and Joipaw
Four innovative startups from Geneva developing solutions in pet health, life sciences, and digital therapeutics have received support from the FONGIT Innovation Fund (FIF). Harantech and Reverso Therapeutics, both UNIGE spin-offs, along with Vibrant, a Wyss Center project, each received a CHF 50,000 FIF Grant to support the translation of their research into tangible health…
Read More7th International Lung Cancer Summit
The 7th International Lung Cancer Summit is taking place on 26 September 2025 in Lausanne and online Expertly chaired by the distinguished duo Solange Peters and Alfredo Addeo, this hybrid conference continues its tradition of excellence by highlighting the latest breakthroughs in lung cancer treatment. With a global lineup of renowned speakers from the…
Read MoreH4 – Who Wants To Be My Caregiver?
On 28 October 2025 the H4 organises the ‘Who wants to be my caregiver?’ competition, a unique event where caregivers form a jury to challenge the solutions offered by healthcare projects. Selected start-ups will pitch to a jury of healthcare professionals, receive actionable feedback… and could win the Hands-on Prizes: a tailor-made immersion in…
Read MoreH4 – Who wants to be my caregiver?
Apply until 14 September 2025 to the H4 ‘Who wants to be my caregiver?’ competition, a unique event where caregivers form a jury to challenge the solutions offered by healthcare projects. Are you developing a solution to improve healthcare or health? Now is the time to test it in the field, get concrete feedback…
Read MoreApertus: A New Opportunity for Swiss Health Valley and Healthcare Innovation
Created through a collaboration between EPFL, ETH Zurich, and the Swiss National Supercomputing Centre (CSCS), Apertus is more than just a technical achievement. It represents a strategic opportunity for the Swiss Health Valley, offering a trusted, transparent, and sovereign foundation for the integration of AI in life sciences and healthcare. A Truly Open AI…
Read More